| 书目名称 | Novel Synthetic Drugs in Migraine | | 编辑 | Paolo Martelletti,Lars Edvinsson | | 视频video | | | 概述 | First book on the novel synthetic treatment of migraine.Compares gepants with triptans or CGRP monoclonal antibodies.Compares ditans with triptans | | 丛书名称 | Headache | | 图书封面 |  | | 描述 | .Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant). These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development.. | | 出版日期 | Book 2022 | | 关键词 | acute treatment; preventive treatment; gepants; ditans; Pharmacological Targets | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-030-95334-8 | | isbn_softcover | 978-3-030-95336-2 | | isbn_ebook | 978-3-030-95334-8Series ISSN 2197-652X Series E-ISSN 2197-6538 | | issn_series | 2197-652X | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
发表于 2025-3-21 17:37:18
